Under the agreement, Synthes has committed to growing Anspach facilities, including the product development and manufacturing capabilities. While Anspach will remain in Florida, Synthes will distribute the products worldwide.
The purchase price of Anspach is not disclosed.
Read the Synthes release on the acquisition.
Read other coverage on Synthes:
– Synthes Reports $907M in Net Sales for 3Q FY 2010
– Court Issued Mixed Ruling in Medtronic’s Appeal of Synthes Patent Dispute
– Synthes Recalling its Synex II Central Body Spinal Implant
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
